Both in Pharmaceuticals
Merck & Co. vs Bristol-Myers Squibb
Over the past year MRK returned +81.3% and BMY returned +35.8%; their daily moves had a correlation of 0.48.
MRK +81.3% BMY +35.8%Growth of $1, one year, split-adjusted
| Metric | MRK | BMY |
|---|---|---|
| Price | $149.52 | $62.48 |
| Market cap | $368.89B | $127.71B |
| Today | +2.18% | +1.78% |
| 1 month | +4.0% | +1.7% |
| 6 months | +33.3% | +7.3% |
| Year to date | +42.0% | +15.8% |
| 1 year | +72.7% | +46.7% |
| Revenue growth (YoY) | +5.1% | +5.7% |
| Gross margin | 73.5% | 71.3% |
| Net margin | −8.0% | 25.6% |
| P/E (TTM) | 116.3× | 13.8× |
| Price / sales | 5.5× | 2.6× |
| Net cash | -$46.77B | -$32.05B |
| Dividend yield | 2.27% | 4.03% |
| Volatility (60d) | 36.0% | 27.3% |
| Short % of float | 1.1% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).